• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄芪甲苷通过 miR-34a/LDHA 通路逆转 MNNG 诱导的大鼠胃癌前病变:对糖酵解的调控。

Astragaloside IV reverses MNNG-induced precancerous lesions of gastric carcinoma in rats: Regulation on glycolysis through miRNA-34a/LDHA pathway.

机构信息

Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.

Guangdong Province Engineering Technology Research Institute of T.C.M., Guangzhou, 510095, China.

出版信息

Phytother Res. 2018 Jul;32(7):1364-1372. doi: 10.1002/ptr.6070. Epub 2018 Mar 26.

DOI:10.1002/ptr.6070
PMID:29577459
Abstract

This study was designed to investigate the precancerous lesions of gastric carcinoma (PLGC)-reversing mechanisms of astragaloside IV (ASIV) in N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced PLGC rats. All rats were sacrificed after 10-week treatment. Gastric tissue was analyzed by using histopathology and electron microscope. To be fully evidenced, LDHA, p53, TIGAR, MCT1, MCT4, HIF-1α, CD147, and miRNA-34a were detected by Western blotting and Real-time Quantitative polymerase chain reaction (RT-qPCR). As histopathology and electron microscope showed, it can be clearly observed that the area of dysplasia was reduced in ASIV groups, indicating that MNNG-induced PLGC was markedly reversed by ASIV. Moreover, compared with model group, a significant decrease in gene expressions of LDHA, MCT1, MCT4, HIF-1α, CD147, and TIGAR was observed whereas miRNA-34a level was increased in ASIV groups. A significant up-regulation induced by MNNG in protein levels of LDHA, MCT1, MCT4, HIF-1α, and CD147 was attenuated in rats treated with ASIV. In contrast, the decreased expression of TIGAR was restored by ASIV. Interestingly, up-regulation of p53 expression induced by MNNG was further increased in ASIV groups. In brief, these results implied that abnormal glycolysis was relieved by ASIV via regulation of the expressions of LDHA, p53, TIGAR, MCT1, MCT4, HIF-1α, CD147, and miRNA-34a.

摘要

本研究旨在探讨黄芪甲苷(ASIV)在 N-甲基-N'-硝基-N-亚硝基胍(MNNG)诱导的胃癌前病变(PLGC)大鼠中逆转的机制。所有大鼠在 10 周治疗后处死。通过组织病理学和电子显微镜分析胃组织。为了充分证明这一点,通过 Western blot 和实时定量聚合酶链反应(RT-qPCR)检测了 LDHA、p53、TIGAR、MCT1、MCT4、HIF-1α、CD147 和 miRNA-34a。组织病理学和电子显微镜显示,ASIV 组的异型增生面积减少,表明 ASIV 显著逆转了 MNNG 诱导的 PLGC。此外,与模型组相比,ASIV 组 LDHA、MCT1、MCT4、HIF-1α、CD147 和 TIGAR 的基因表达显著降低,而 miRNA-34a 水平升高。ASIV 减弱了 MNNG 诱导的 LDHA、MCT1、MCT4、HIF-1α 和 CD147 蛋白水平的显著上调。相反,ASIV 恢复了 TIGAR 的下调表达。有趣的是,MNNG 诱导的 p53 表达上调在 ASIV 组进一步增加。总之,这些结果表明,ASIV 通过调节 LDHA、p53、TIGAR、MCT1、MCT4、HIF-1α、CD147 和 miRNA-34a 的表达,缓解了异常糖酵解。

相似文献

1
Astragaloside IV reverses MNNG-induced precancerous lesions of gastric carcinoma in rats: Regulation on glycolysis through miRNA-34a/LDHA pathway.黄芪甲苷通过 miR-34a/LDHA 通路逆转 MNNG 诱导的大鼠胃癌前病变:对糖酵解的调控。
Phytother Res. 2018 Jul;32(7):1364-1372. doi: 10.1002/ptr.6070. Epub 2018 Mar 26.
2
Protective effects of Weipixiao decoction against MNNG-induced gastric precancerous lesions in rats.胃痞消方对 MNNG 致大鼠胃癌前病变的保护作用。
Biomed Pharmacother. 2019 Dec;120:109427. doi: 10.1016/j.biopha.2019.109427. Epub 2019 Oct 21.
3
The gastric mucosal protective effects of astragaloside IV in mnng-induced GPL rats.黄芪甲苷对 MNNG 致 GPL 大鼠胃黏膜的保护作用。
Biomed Pharmacother. 2018 Aug;104:291-299. doi: 10.1016/j.biopha.2018.04.013. Epub 2018 May 25.
4
Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.黄芪甲苷IV通过调节NF-κB/PGC-1α信号介导的能量生物合成来预防异丙肾上腺素诱导的心肌肥大。
PLoS One. 2015 Mar 4;10(3):e0118759. doi: 10.1371/journal.pone.0118759. eCollection 2015.
5
Weipixiao attenuate early angiogenesis in rats with gastric precancerous lesions.胃康片抑制胃癌前病变大鼠早期血管生成。
BMC Complement Altern Med. 2018 Sep 10;18(1):250. doi: 10.1186/s12906-018-2309-3.
6
Astragaloside IV attenuates injury caused by myocardial ischemia/reperfusion in rats via regulation of toll-like receptor 4/nuclear factor-κB signaling pathway.黄芪甲苷通过调节 Toll 样受体 4/核因子-κB 信号通路减轻大鼠心肌缺血再灌注损伤。
Phytother Res. 2015 Apr;29(4):599-606. doi: 10.1002/ptr.5297. Epub 2015 Jan 21.
7
Xiao Tan He Wei Decoction reverses MNNG-induced precancerous lesions of gastric carcinoma in vivo and vitro: Regulation of apoptosis through NF-κB pathway.小檗碱和胃汤在体内外逆转MNNG诱导的胃癌癌前病变:通过NF-κB途径调节细胞凋亡。
Biomed Pharmacother. 2018 Dec;108:95-102. doi: 10.1016/j.biopha.2018.09.012. Epub 2018 Sep 12.
8
Astragaloside IV protects blood-brain barrier integrity from LPS-induced disruption via activating Nrf2 antioxidant signaling pathway in mice.黄芪甲苷通过激活 Nrf2 抗氧化信号通路保护 LPS 诱导的小鼠血脑屏障完整性受损。
Toxicol Appl Pharmacol. 2018 Feb 1;340:58-66. doi: 10.1016/j.taap.2017.12.019. Epub 2017 Dec 30.
9
Gastro-Protective Effects of Calycosin Against Precancerous Lesions of Gastric Carcinoma in Rats.毛蕊异黄酮对大鼠胃癌前病变的胃保护作用。
Drug Des Devel Ther. 2020 Jun 9;14:2207-2219. doi: 10.2147/DDDT.S247958. eCollection 2020.
10
Astragaloside IV improves the isoproterenol-induced vascular dysfunction via attenuating eNOS uncoupling-mediated oxidative stress and inhibiting ROS-NF-κB pathways.黄芪甲苷通过减轻eNOS解偶联介导的氧化应激和抑制ROS-NF-κB途径来改善异丙肾上腺素诱导的血管功能障碍。
Int Immunopharmacol. 2016 Apr;33:119-27. doi: 10.1016/j.intimp.2016.02.009. Epub 2016 Feb 21.

引用本文的文献

1
Crosstalk between bile acids and gut microbiota: a potential target for precancerous lesions of gastric cancer.胆汁酸与肠道微生物群之间的相互作用:胃癌癌前病变的一个潜在靶点。
Front Pharmacol. 2025 Mar 13;16:1533141. doi: 10.3389/fphar.2025.1533141. eCollection 2025.
2
Reversal of chemotherapy resistance in gastric cancer with traditional Chinese medicine as sensitizer: potential mechanism of action.以中药为增敏剂逆转胃癌化疗耐药性:潜在作用机制
Front Oncol. 2025 Feb 20;15:1524182. doi: 10.3389/fonc.2025.1524182. eCollection 2025.
3
Natural products based on Correa's cascade for the treatment of gastric cancer trilogy: Current status and future perspective.
基于科雷亚级联反应的天然产物用于胃癌三部曲治疗:现状与未来展望。
J Pharm Anal. 2025 Feb;15(2):101075. doi: 10.1016/j.jpha.2024.101075. Epub 2024 Aug 19.
4
Mechanisms of (Fisch.) Bge. var. mongholicus (Bge.) Hsiao (huang qi) and (Oliv.) Diels (dang gui) in Ameliorating Hypoxia and Angiogenesis to Delay Pulmonary Nodule Malignant Transformation.蒙古黄芪(Fisch.)Bge. 变种蒙古黄芪(Bge.)Hsiao(黄芪)和当归(Oliv.)Diels(当归)改善缺氧和血管生成以延缓肺结节恶性转化的机制。
Integr Cancer Ther. 2025 Jan-Dec;24:15347354241311917. doi: 10.1177/15347354241311917.
5
Weiwei Decoction alleviates gastric intestinal metaplasia through the olfactomedin 4/nucleotide-binding oligomerization domain 1/caudal-type homeobox gene 2 signaling pathway.萎胃汤通过嗅觉介质4/核苷酸结合寡聚化结构域1/尾型同源框基因2信号通路减轻胃肠化生。
World J Gastrointest Oncol. 2024 Jul 15;16(7):3211-3229. doi: 10.4251/wjgo.v16.i7.3211.
6
Research Progress on the Anti-Cancer Effects of Saponins and Their Mechanisms of Action.皂苷的抗肿瘤作用及其作用机制的研究进展。
Molecules. 2024 Jul 18;29(14):3388. doi: 10.3390/molecules29143388.
7
Revolutionizing Gastric Cancer Prevention: Novel Insights on Gastric Mucosal Inflammation-Cancer Transformation and Chinese Medicine.革新胃癌预防:关于胃黏膜炎症 - 癌转化及中医的新见解
Chin J Integr Med. 2024 Apr 27. doi: 10.1007/s11655-024-3806-5.
8
Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer.靶向瓦伯格效应:从分子机制到癌症传统与创新治疗策略的新视角
Acta Pharm Sin B. 2024 Mar;14(3):953-1008. doi: 10.1016/j.apsb.2023.12.003. Epub 2023 Dec 16.
9
Gastric precancerous lesions:occurrence, development factors, and treatment.胃癌前病变:发生、发展因素及治疗
Front Oncol. 2023 Aug 30;13:1226652. doi: 10.3389/fonc.2023.1226652. eCollection 2023.
10
The effect of phytochemicals in N-methyl-N-nitro-N-nitroguanidine promoting the occurrence and development of gastric cancer.植物化学物质在N-甲基-N-硝基-N-亚硝基胍促进胃癌发生发展中的作用。
Front Pharmacol. 2023 Jun 29;14:1203265. doi: 10.3389/fphar.2023.1203265. eCollection 2023.